Campylobacter Gastroenteritis (Campylobacter jejuni)

Overview


Plain-Language Overview

Campylobacter Gastroenteritis is an infection that affects the digestive system, specifically the intestines. It is caused by the bacteria Campylobacter jejuni, which is commonly found in contaminated food or water. This infection leads to symptoms such as diarrhea, often bloody, abdominal pain, fever, and sometimes nausea or vomiting. The bacteria cause inflammation in the intestines, which disrupts normal digestion and absorption. Most people recover within a week, but the illness can be more severe in young children, the elderly, or those with weakened immune systems. The main health impact is dehydration due to diarrhea and the discomfort from intestinal inflammation.

Clinical Definition

Campylobacter Gastroenteritis is an acute infectious enteritis caused primarily by the gram-negative, curved rod bacterium Campylobacter jejuni. The pathogenesis involves bacterial invasion of the intestinal mucosa, leading to inflammation and mucosal damage predominantly in the ileum and colon. This results in symptoms of bloody diarrhea, fever, and abdominal cramping. The infection is a common cause of bacterial gastroenteritis worldwide and is typically transmitted via ingestion of contaminated poultry, unpasteurized milk, or water. The clinical significance includes potential complications such as Guillain-Barré syndrome and reactive arthritis. Diagnosis is important to differentiate from other causes of infectious diarrhea and to guide management.

Inciting Event

  • Ingestion of contaminated food or water containing Campylobacter jejuni initiates infection.

  • Consumption of raw or undercooked poultry is the most common source of exposure.

  • Contact with infected animals or their feces can lead to transmission.

  • Cross-contamination during food preparation facilitates bacterial spread.

Latency Period

  • Symptoms typically develop 2 to 5 days after ingestion of contaminated material.

  • Incubation period ranges from 1 to 7 days, with most cases presenting within 3 days.

  • Latency may be shorter in immunocompromised hosts.

Diagnostic Delay

  • Initial symptoms often mimic viral gastroenteritis, leading to misdiagnosis.

  • Lack of routine stool culture for Campylobacter delays identification.

  • Empiric treatment without microbiologic confirmation can obscure diagnosis.

  • Mild cases may not seek medical attention, delaying diagnosis.

Clinical Presentation


Signs & Symptoms

  • Watery to bloody diarrhea is the hallmark symptom, often with mucus.

  • Crampy abdominal pain frequently precedes diarrhea onset.

  • Fever and malaise accompany systemic infection.

  • Nausea and vomiting may occur but are less prominent.

  • Tenesmus and urgency can be present due to colonic inflammation.

History of Present Illness

  • Acute onset of fever, abdominal cramping, and watery to bloody diarrhea is typical.

  • Symptoms often begin with prodromal malaise and headache followed by diarrhea.

  • Diarrhea may be frequent and accompanied by tenesmus and urgency.

  • Duration of illness is usually less than one week, but can be prolonged in some cases.

  • Post-infectious complications such as Guillain-Barré syndrome may develop days to weeks later.

Past Medical History

  • History of recent travel to endemic areas increases suspicion for infection.

  • Prior episodes of gastrointestinal infections may predispose to altered gut flora.

  • Use of acid-suppressing medications can increase risk of infection.

  • Immunosuppressive conditions or therapies may worsen disease severity.

Family History

  • No significant familial genetic predisposition is associated with Campylobacter jejuni infection.

  • Family members may share exposure risks due to common dietary or environmental sources.

  • Rarely, familial clustering occurs due to shared contaminated food or water.

Physical Exam Findings

  • Fever and signs of systemic infection such as tachycardia and mild dehydration are common.

  • Abdominal tenderness, especially in the lower quadrants, may be present without peritoneal signs.

  • Hyperactive bowel sounds are often noted due to increased intestinal motility.

  • Mild hepatomegaly can occasionally be detected in severe cases.

  • Signs of volume depletion such as dry mucous membranes and decreased skin turgor may be observed.

Diagnostic Workup


Diagnostic Criteria

Diagnosis is established by stool culture demonstrating growth of Campylobacter jejuni, which is a microaerophilic, gram-negative curved rod. Stool PCR assays can also confirm the presence of Campylobacter DNA with high sensitivity. Clinical presentation with bloody diarrhea, fever, and abdominal pain supports the diagnosis. Additional laboratory findings may include mild leukocytosis and elevated inflammatory markers. Identification of the organism in stool remains the gold standard for confirmation.

Pathophysiology


Key Mechanisms

  • Invasion of intestinal mucosa by Campylobacter jejuni leads to inflammatory diarrhea.

  • Production of cytotoxins causes mucosal damage and contributes to colitis.

  • Activation of host immune response results in recruitment of neutrophils and release of proinflammatory cytokines.

  • Disruption of tight junctions increases intestinal permeability causing secretory diarrhea.

  • Molecular mimicry between bacterial antigens and host nerve tissue can trigger Guillain-Barré syndrome as a post-infectious complication.

InvolvementDetails
Organs

Small intestine is the main organ affected, where bacterial invasion and toxin release cause gastroenteritis symptoms.

Colon may also be involved, especially in severe or invasive infections causing bloody diarrhea.

Tissues

Intestinal mucosa is the primary site of inflammation and damage leading to diarrhea and abdominal pain.

Lamina propria contains immune cells that mediate the inflammatory response to infection.

Cells

Neutrophils mediate acute inflammatory response causing mucosal damage in the intestinal epithelium.

Macrophages phagocytose bacteria and release proinflammatory cytokines contributing to tissue injury.

Enterocytes are the primary intestinal epithelial cells affected by bacterial invasion and toxin-mediated damage.

Chemical Mediators

Interleukin-8 (IL-8) recruits neutrophils to the site of infection, amplifying inflammation.

Tumor necrosis factor-alpha (TNF-α) promotes inflammation and contributes to mucosal injury.

Cytolethal distending toxin (CDT) produced by Campylobacter jejuni causes DNA damage and cell cycle arrest in host cells.

Treatments


Pharmacological Treatments

  • Azithromycin

    • Mechanism:
      • Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effective against Campylobacter jejuni.

    • Side effects:
      • Gastrointestinal upset

      • QT prolongation

      • Allergic reactions

    • Clinical role:
      • First-line

  • Fluoroquinolones

    • Mechanism:
      • Inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication in Campylobacter jejuni.

    • Side effects:
      • Tendonitis

      • QT prolongation

      • Gastrointestinal upset

    • Clinical role:
      • Second-line

Non-pharmacological Treatments

  • Maintain adequate hydration with oral rehydration solutions to prevent dehydration from diarrhea.

  • Avoid anti-motility agents as they may prolong infection and increase risk of complications.

Prevention


Pharmacological Prevention

  • No approved vaccine currently exists for Campylobacter jejuni.

  • Antibiotic prophylaxis is not routinely recommended due to resistance concerns.

  • Macrolides such as azithromycin are used for treatment but not prevention.

  • No effective chemoprophylaxis is established for travelers or contacts.

  • Supportive care remains the mainstay of prevention of complications.

Non-pharmacological Prevention

  • Proper food handling and cooking to avoid ingestion of contaminated poultry or meat.

  • Hand hygiene with soap and water after contact with animals or raw food.

  • Avoidance of unpasteurized milk and untreated water sources.

  • Safe drinking water and sanitation reduce transmission risk.

  • Education on avoiding cross-contamination in kitchen environments.

Outcome & Complications


Complications

  • Guillain-Barré syndrome is a serious autoimmune neuropathy triggered by molecular mimicry.

  • Reactive arthritis can develop days to weeks after infection.

  • Bacteremia and systemic infection occur mainly in immunocompromised hosts.

  • Hemolytic uremic syndrome is a rare but severe complication.

  • Intestinal perforation is uncommon but possible in severe colitis.

Short-term Sequelae Long-term Sequelae
  • Dehydration from profuse diarrhea requiring fluid resuscitation.

  • Electrolyte imbalances such as hypokalemia due to diarrhea losses.

  • Transient bacteremia causing fever and systemic symptoms.

  • Post-infectious irritable bowel syndrome may develop after acute illness.

  • Mucosal ulceration leading to bloody stools and abdominal pain.

  • Chronic reactive arthritis with joint pain and swelling lasting months.

  • Persistent gastrointestinal dysmotility causing chronic diarrhea or constipation.

  • Guillain-Barré syndrome with potential long-term neuromuscular deficits.

  • Post-infectious fatigue syndrome with prolonged malaise.

  • Increased risk of inflammatory bowel disease flare-ups in predisposed individuals.

Differential Diagnoses


Campylobacter Gastroenteritis (Campylobacter jejuni) versus Salmonella Gastroenteritis

Campylobacter Gastroenteritis (Campylobacter jejuni)

Salmonella Gastroenteritis

Gram-negative curved rods, microaerophilic Campylobacter jejuni

Gram-negative bacilli, facultative intracellular bacteria of the genus Salmonella

Consumption of undercooked poultry or unpasteurized milk

Consumption of contaminated poultry, eggs, or contact with reptiles

Diarrhea with possible bloody stools, fever, and abdominal pain, usually self-limited within 1 week

Often self-limited diarrhea lasting 4-7 days, may cause bacteremia in immunocompromised

Campylobacter Gastroenteritis (Campylobacter jejuni) versus Shigella Gastroenteritis

Campylobacter Gastroenteritis (Campylobacter jejuni)

Shigella Gastroenteritis

Motile, gram-negative curved rods causing mucosal inflammation

Non-motile, gram-negative bacilli causing invasive colitis

Bloody diarrhea with fever but less prominent tenesmus

Frequent bloody diarrhea with high fever and tenesmus

Positive stool culture or PCR for Campylobacter jejuni

Positive stool culture for Shigella species

Campylobacter Gastroenteritis (Campylobacter jejuni) versus Enterohemorrhagic Escherichia coli (EHEC) Infection

Campylobacter Gastroenteritis (Campylobacter jejuni)

Enterohemorrhagic Escherichia coli (EHEC) Infection

Gram-negative curved rod, invasive organism

Gram-negative rod producing Shiga toxin, non-invasive

Bloody diarrhea often accompanied by fever

Watery diarrhea progressing to bloody diarrhea without fever

Rarely associated with HUS

High risk of hemolytic uremic syndrome (HUS)

Campylobacter Gastroenteritis (Campylobacter jejuni) versus Clostridium difficile Colitis

Campylobacter Gastroenteritis (Campylobacter jejuni)

Clostridium difficile Colitis

Recent ingestion of undercooked poultry or unpasteurized dairy

Recent antibiotic use or hospitalization

Diarrhea often bloody with fever and abdominal cramping

Profuse watery diarrhea with pseudomembranous colitis

Positive stool culture or PCR for Campylobacter jejuni

Positive stool toxin assay for C. difficile toxins A and B

Campylobacter Gastroenteritis (Campylobacter jejuni) versus Yersinia enterocolitica Infection

Campylobacter Gastroenteritis (Campylobacter jejuni)

Yersinia enterocolitica Infection

Consumption of undercooked poultry or unpasteurized milk

Consumption of contaminated pork or unpasteurized milk

Diarrhea with fever and abdominal pain, less commonly mimics appendicitis

Diarrhea with mesenteric lymphadenitis mimicking appendicitis

Positive stool culture or PCR for Campylobacter jejuni

Positive stool culture for Yersinia enterocolitica

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.